{"version":"1.0","provider_name":"Site da Brakke Consulting","provider_url":"https:\/\/brakkeconsulting.com\/pt","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"qn9SiPamsC\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/22341\/\">Not\u00edcias e notas sobre sa\u00fade animal de 15 de mar\u00e7o de 2002<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/pt\/22341\/embed\/#?secret=qn9SiPamsC\" width=\"600\" height=\"338\" title=\"&#8220;Animal Health News &#038; Notes for March 15, 2002&#8221; &#8212; Brakke Consulting Website\" data-secret=\"qn9SiPamsC\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"**************************************************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for March 15, 2002 Copyright &copy; Brakke Consulting, Inc. **************************************************************** Company Earnings Releases &nbsp; &gt;&nbsp; In 2001 Intervet International successfully continued its growth pattern of previous years with considerable sales gains and improved margins. The animal health business of Akzo Nobel closed the year 2001 with sales of EUR 1,096 million ($971 million).&nbsp; In 2001, Intervet placed a stronger focus on strengthening its presence in key country markets, notably the United States. Intervet expects further growth in the companion animal pharmaceuticals segment in the US.&nbsp; The spread of BSE in Western Europe and the foot and mouth disease (FMD) outbreak in the first half of 2001 put significant pressure on the European market.&nbsp; In total, nearly 20 new vaccine and pharmaceutical products were successfully launched during 2001. (company press release) &gt;&nbsp; PETsMART, Inc. announced results for its fiscal fourth quarter and full year which ended February 3, 2002. The company reported fourth quarter 2001 net income of $29.7 million versus a net loss of $(27.2) million for the fourth quarter in 2000. For the fiscal year 2001, PETsMART generated net income of $39.6 million compared to a net loss of $(30.9) million for the fiscal year 2000, a year-over-year increase of $70.5 million.&nbsp; Sales for the fourth quarter of 2001 increased 21%View Full Post;"}